Beating the heart failure epidemic: can emerging cell therapies deliver what conventional approaches cannot?

Saltzman RG, Asensi KD, Chakraborty A, Kulandavelu S, Hare JM

Open source

DOI
10.1080/14779072.2026.2735936
Published
2026 Sep 24
Container
Expert review of cardiovascular therapy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14779072.2026.2735936,
  title = {Beating the heart failure epidemic: can emerging cell therapies deliver what conventional approaches cannot?},
  author = {Saltzman RG and Asensi KD and Chakraborty A and Kulandavelu S and Hare JM},
  year = {2026},
  journal = {Expert review of cardiovascular therapy},
  doi = {10.1080/14779072.2026.2735936},
  url = {https://doi.org/10.1080/14779072.2026.2735936}
}

RIS

TY  - JOUR
TI  - Beating the heart failure epidemic: can emerging cell therapies deliver what conventional approaches cannot?
AU  - Saltzman RG
AU  - Asensi KD
AU  - Chakraborty A
AU  - Kulandavelu S
AU  - Hare JM
PY  - 2026
JO  - Expert review of cardiovascular therapy
DO  - 10.1080/14779072.2026.2735936
UR  - https://doi.org/10.1080/14779072.2026.2735936
ER  - 

APA

RG, S., KD, A., A, C., S, K., & JM, H. (2026). Beating the heart failure epidemic: can emerging cell therapies deliver what conventional approaches cannot?. Expert review of cardiovascular therapy. https://doi.org/10.1080/14779072.2026.2735936

Source records